DDD Pacing in Hypertrophic Cardiomyopathy: State of the Art

  • S. Betocchi
  • M. A. Losi
  • C. Briguori
  • M. Chiariello
Conference paper


Hypertrophic cardiomyopathy (HCM) is a primary myocardial disease, whose typical pathophysiological features include normal systolic dynamics, impaired diastolic function [1–4], and, in about one fourth of patients, left ventricular (LV) outflow tract obstruction [5–8].


Diastolic Function Outflow Tract Hypertrophic Cardiomyopathy Left Ventricular Outflow Tract Obstruction Hypertrophic Obstructive Cardiomyopathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sanderson JE, Gibson DG, Brown DJ, Goodwin JF (1977) Left ventricular filling in hypertrophic cardiomyopathy. Br Heart J 39:661–670PubMedCrossRefGoogle Scholar
  2. 2.
    Bonow RO, Frederick TM, Bacharach SL, Green MV, Goose PW, Maron BJ, Rosing DR (1983) Atrial systole and left ventricular filling in patients with hypertrophic cardiomyopathy. Am J Cardiol 51:1386–1391PubMedCrossRefGoogle Scholar
  3. 3.
    Betocchi S, Bonow RO, Bacharach SL, Rosing DR, Maron BJ, Green MV (1986) Isovolumic relaxation period in hypertrophie cardiomyopathy: assessment by radionuclide angiography. J Am Coll Cardiol 7:74–81PubMedCrossRefGoogle Scholar
  4. 4.
    Hess OM, Murakami T, Krayenbuehl HP (1986) Does verapamil improve left ventricular relaxation in patients with myocardial hypertrophy? Circulation 74:530–543PubMedCrossRefGoogle Scholar
  5. 5.
    Maron BJ, Gottdiener JS, Arce J, Rosing DR, Wesley YE, Epstein SE (1985) Dynamic subaortic obstruction in hypertrophie cardiomyopathy: analysis by pulsed Doppler echocardiography. J Am Coll Cardiol 6:1–15PubMedCrossRefGoogle Scholar
  6. 6.
    Maron BJ, Epstein SE (1986) Clinical significance and therapeutic implications of the left ventricular outflow tract pressure gradient in hypertrophie cardiomyopathy. Am J Cardiol 58:1093–1096PubMedCrossRefGoogle Scholar
  7. 7.
    Seiler C, Hess OM, Schoenbeck M, Turina J, Jenni R, Turina M, Krayenbuehl HP (1991) Long-term follow-up of medical versus surgical therapy for hypertrophie cardiomyopathy: a retrospective study. J Am Coll Cardiol 17:634–642PubMedCrossRefGoogle Scholar
  8. 8.
    Kaltenbach M, Hopf R, Kober G, Bussman WD, Keller M, Paterson Y (1979) Treatment of hypertrophie cardiomyopathy with verapamil. Br Heart J 42:35–42PubMedCrossRefGoogle Scholar
  9. 9.
    Morrow AG, Fogarty TJ, Hannah H III, Braunwald E (1968) Operative treatment in idiopatic hypertrophie subaortic stenosis: techniques and the results of preoperative and postoperative clinical and hemodynamic assessment. Circulation 37:589–596PubMedCrossRefGoogle Scholar
  10. 10.
    Hassenstein P, Walther H, Dittrich J (1975) Haemodynamische Veränderungen durch einfache und gekoppelte Stimulation bei Patienten mit obstruktiver Kardiomyopathie. Verh Dtsch Ges Inn Med 81:170–173PubMedGoogle Scholar
  11. 11.
    Duck HJ, Hutschemeister W, Paneau H, Trenckmann H (1984) Atrio-ventricular Stimulation with reduced AV-delay time as a therapeutic principle in hypertrophie obstructive cardiomyopathy. Z Gesamte Inn Med 39:437–447PubMedGoogle Scholar
  12. 12.
    McDonald K, McWilliam E, O’Keeffe B, Maurer B (1988) Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy. Eur Heart J 9:893–898PubMedGoogle Scholar
  13. 13.
    Fananapazir L, Cannon RO III, Tripodi D, Panza JA (1992) Impact of dual-chamber permanent pacing in patients with obstructive hypertrophie cardiomyopathy with symptoms refractory to verapamil and β-adrenergic blocker therapy. Circulation 85:2149–2161PubMedCrossRefGoogle Scholar
  14. 14.
    Jeanrenaud X, Goy JJ, Kappenberger L (1992) Effects of dual-chamber pacing in hypertrophie obstructive cardiomyopathy. Lancet 339:1318–1323PubMedCrossRefGoogle Scholar
  15. 15.
    Betocchi S, Losi MA, Piscione F, Boccalatte M, Pace L, Golino P, Perrone-Filardi P, Briguori C, Franculli, F, Pappone C, Salvatore M, Chiariello M (1996) Effects of dualchamber pacing in hypertrophic cardiomyopathy on left ventricular outflow tract obstruction and on diastolic function. Am J Cardiol 77:498–504PubMedCrossRefGoogle Scholar
  16. 16.
    Losi MA, Betocchi S, Briguori C, Piscione F, Manganelli F, Ciampi Q, Stabile G, Chiariello M (1998) Dual chamber pacing in hypertrophic cardiomyopathy: influence of atrio-ventricular delay on left ventricular outflow tract obstruction. Cardiology 89:8–13PubMedCrossRefGoogle Scholar
  17. 17.
    Zile MR, Blaunstein AS, Shimizu G, Gaasch WH (1987) Right ventricular pacing reduces the rate of left ventricular relaxation and filling. J Am Coll Cardiol 10:702–709PubMedCrossRefGoogle Scholar
  18. 18.
    Betocchi S, Piscione F, Villari B, Pace L, Ciarmiello A, Perrone-Filardi P, Salvatore C, Salvatore M, Chiariello M (1993) Effects of induced asynchrony on left ventricular diastolic function in patients with coronary artery disease. J Am Coll Cardiol 21:1124–1131PubMedCrossRefGoogle Scholar
  19. 19.
    Nishimura RA, Hayes DL, Ilstrup DM, Holmes DR, Tajik JA (1996) Effect of dualchamber pacing on systolic and diastolic function in patients with hypertrophie cardiomyopathy: acute Doppler echocardiographic and catheterization hemodynamic study. J Am Coll Cardiol 27:421–430PubMedCrossRefGoogle Scholar
  20. 20.
    Gaasch WH, Blaunstein AS, Andrias CW, Donahue RP, Avitall B (1980). Myocardial relaxation. II. Hemodynamic determinants of rate of left ventricular isovolumic pressure decline. Am J Physiol 239:H1–H6PubMedGoogle Scholar
  21. 21.
    Ishida Y, Meisner JS, Tsujoka K, Gallo JI, Yoran C, Frater RWM, Yellin EL (1986) Left ventricular filling dynamics: influence of left ventricular relaxation and left atrial pressure. Circulation 74:187–196PubMedCrossRefGoogle Scholar
  22. 22.
    Fananapazir L, Epstein ND, Curiel RV, Panza J, Tripodi D, McAreavey D (1994) Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophie cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 90:2731–2742Google Scholar
  23. 23.
    Slade AKB, Sadoul N, Shapiro L, Choinowska L, Simon JP, Saumarez RC, Dodinot B, Camm AJ, McKenna WJ, Aliot E (1996) DDD pacing in hypertrophie cardiomyopathy: a multicentre clinical experience. Heart 75:44–49PubMedCrossRefGoogle Scholar
  24. 24.
    Rishi F, Hulse JE, Auld DO, McRae G, Kaltman J, Kanter K, Williams W, Campbell RM (1997) Effects of dual-chamber pacing for pediatrie patients with hypertrophie cardiomyopathy. J Am Coll Cardiol 29:734–740PubMedCrossRefGoogle Scholar
  25. 25.
    Posma JL, Blanksma PK, Van der Wall EE, Vaalburg W, Crijins HJ, Lie KI (1996) Effects of permanent dual chamber pacing on myocardial perfusion in symptomatic hypertrophie cardiomyopathy. Heart 76:358–362PubMedCrossRefGoogle Scholar
  26. 26.
    Betocchi S, Losi MA, Briguori C, Manganelli F, Ciampi Q, Boccalatte M, Gottilla R, Coltorti F, Santomauro M, Chiariello M (1997) Long-term dual-chamber pacing reduces outflow tract obstruction but impairs diastolic function in hypertrophie cardiomyopathy. Eur Heart J 18:604 (abstr)Google Scholar
  27. 27.
    Nishimura RA, Trusty JM, Hayes DL, Ilstrup DM, Larson DR, Hayes SH, Allison TG, Tajik J (1997) Dual-chamber pacing for hypertrophie obstructive cardiomyopathy: a randomized, double-blind crossover trial. J Am Coll Cardiol 29:435–441PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1998

Authors and Affiliations

  • S. Betocchi
  • M. A. Losi
  • C. Briguori
  • M. Chiariello

There are no affiliations available

Personalised recommendations